Cerus Corporation (NASDAQ: CERS) announced today an arrangement with LifeSouth Community Blood Centers to aid as a creative associate for INTERCEPT® Fibrinogen Complex, the company’s pathogen abridged cryoprecipitate fibrinogen multifaceted creation.  LifeSouth is the fifth manufacture associate for INTERCEPT Fibrinogen Complex LifeSouth is the fifth manufacture associate for INTERCEPT Fibrinogen […]